UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000038296 |
|---|---|
| Receipt number | R000043525 |
| Scientific Title | Clinical Benefits of Following Therapy after Anti-HER2 Standard Therapy for HER2-positive, Unresectable and/or Metastatic Breast Cancer: a Retrospective Registry Study (KBCSG-TR 1917) |
| Date of disclosure of the study information | 2019/10/15 |
| Last modified on | 2020/06/16 09:35:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/10/15 16:35:38 | ||
| 2 | Update | 2020/01/29 11:01:30 | Org. issuing International ID_1 |
|
| 3 | Update | 2020/01/29 11:03:04 | Recruitment status Date of closure to data entry Date trial data considered complete |
|
| 4 | Update | 2020/01/30 09:44:17 | Number of participants that the trial has enrolled |
|
| 5 | Update | 2020/06/16 09:35:20 | Recruitment status |
